Загрузка...
Recent advances of bispecific antibodies in solid tumors
Cancer immunotherapy is the most exciting advancement in cancer therapy. Similar to immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T), bispecific antibody (BsAb) is attracting more and more attention as a novel strategy of antitumor immunotherapy. BsAb not only offers an effect...
Сохранить в:
| Опубликовано в: : | J Hematol Oncol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607507/ https://ncbi.nlm.nih.gov/pubmed/28931402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0522-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|